Avadel Pharmaceuticals (AVDL) Receivables - Net (2016 - 2020)
Historic Receivables - Net for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Q2 2020 value amounting to $5.7 million.
- Avadel Pharmaceuticals' Receivables - Net fell 4404.25% to $5.7 million in Q2 2020 from the same period last year, while for Jun 2020 it was $5.7 million, marking a year-over-year decrease of 4404.25%. This contributed to the annual value of $8.3 million for FY2019, which is 2691.09% down from last year.
- According to the latest figures from Q2 2020, Avadel Pharmaceuticals' Receivables - Net is $5.7 million, which was down 4404.25% from $8.8 million recorded in Q1 2020.
- Over the past 5 years, Avadel Pharmaceuticals' Receivables - Net peaked at $24.1 million during Q3 2017, and registered a low of $4.9 million during Q1 2016.
- For the 5-year period, Avadel Pharmaceuticals' Receivables - Net averaged around $12.5 million, with its median value being $11.6 million (2018).
- Per our database at Business Quant, Avadel Pharmaceuticals' Receivables - Net skyrocketed by 103477.83% in 2016 and then plummeted by 5961.38% in 2018.
- Quarter analysis of 5 years shows Avadel Pharmaceuticals' Receivables - Net stood at $17.8 million in 2016, then decreased by 17.12% to $14.8 million in 2017, then decreased by 23.37% to $11.3 million in 2018, then decreased by 26.91% to $8.3 million in 2019, then tumbled by 31.26% to $5.7 million in 2020.
- Its last three reported values are $5.7 million in Q2 2020, $8.8 million for Q1 2020, and $8.3 million during Q4 2019.